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Changes in intracellular calcium are necessary for the successful progression of mitosis in many cells. Both elevation and
reduction in intracellular calcium can disrupt mitosis by mechanisms that remain ill deﬁned. In this study we explore the role of
transmembrane voltage-gated calcium channels (CaV channels) as regulators of mitosis in the mouse corticotroph cell line (AtT-
20). We report that the nifedipine-sensitive isoform CaV1.2 is localized to the “poleward side” of kinetechores during metaphase
and at the midbody during cytokinesis. A second nifedipine-sensitive isoform, CaV1.3, is present at the mid-spindle zone in
telophase, but is also seen at the midbody. Nifedipine reduces the rate of cell proliferation, and, utilizing time-lapse microscopy,
we show that this is due to a block at the prometaphase stage of the cell cycle. Using Fluo-4 we detect calcium ﬂuxes at sites
corresponding to the mid-spindle zone and the midbody region. Another calcium dye, Fura PE3/AM, causes an inhibition of
mitosis prior to anaphase that we attribute to a chelation of intracellular calcium. Our results demonstrate a novel, isoform-
speciﬁc localization of CaV1 channels during cell division and suggest a possible role for these channels in the calcium-dependent
events underlying mitotic progression in pituitary corticotrophs.
Copyright © 2009 Karen J. Loechner et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Voltage-dependent calcium channels (CaV channels) are
multisubunit transmembrane proteins that are mediators of
entryof extracellularcalciumions into cellsofnerve, muscle,
and endocrine tissues [1]. Genomic studies have identiﬁed
3 families for the ten genes that encode the alpha1 subunits
designated CaV1, CaV2, and CaV3 [2]. The diversity of CaV
channel genes allows for a large number of channel isoforms,
and these diﬀerent isoforms are often expressed in the same
cell. By mediating changes in intracellular free calcium,
CaV channels act as key mediators of signaling events such
as cell depolarization, neurotransmitter and neuropeptide
secretion, and regulation of gene expression [3, 4]. An
important objective in calcium channel biology, therefore, is
to understand the speciﬁc role(s) for each channel isoform,
and their integration in diﬀerent cellular events.
One well-established role of calcium channels is the cou-
pling of membrane depolarization to release of neurotrans-
mitters [5, 6]. Both CaV2.1 and CaV2.2 have been shown
to interact directly with, and be modulated by, proteins
that comprise the neurotransmitter release apparatus (the
SNARE complex). Colocalization of channels and the release
machinery facilitates coupling between the active calcium
channels and the calcium dependent fusion of transmitter-
containing vesicles with plasma membrane.
In neuroendocrine cells, a similar coupling between
CaV1 channels and release machinery is thought to underlie
secretion of peptides such as insulin, growth hormone, or
ACTH [7, 8]. The pituitary corticotroph cell line, AtT-20, is a
well-establishedmodelsystemforstudiesofACTHsecretion.
These cells express multiple isoforms of CaV, yet only the
CaV1 channels are coupled to CRH- or depolarization-
stimulated secretion of ACTH [9, 10]. In a recent study we2 International Journal of Cell Biology
examined the cellular distribution of CaV1 channels and
SNARE proteins in AtT-20s cells and found colocalization of
CaV1.2, but not CaV1.3, with components of the synaptic
machinery and releasable peptide [11]. In the course of this
studyweobservedCaV1channelslocalizednearcomponents
of the mitotic apparatus in dividing cells. These observations
suggested that the AtT-20 cell could provide a useful model
to examine the possible role for CaV1 channels in another
cellular function, mitosis.
A role for calcium signaling in mitosis has been inferred
fordecades,yetthemechanismunderlying calciumelevation
during cell division has, to date, not been elucidated. Studies
have established a role for calcium and/or demonstrated
alterations in calcium gradients during mitosis [12–19].
Calcium is involved in regulating mitotic checkpoints; the
critical point at which progression through mitotic stages is
closely regulated has also been shown [20–24]. Furthermore,
the role of calcium-dependent kinases in mitosis has also
been examined (reviewed in [25]).
The CaV channels observed in dividing AtT-20 cells
represent a possible contributor to intracellular calcium
ﬂuxes during mitosis. Antagonists to the CaV1 subtype
(dihydropyridines (DHPs)) have been reported to block
mitosis in a number of systems [26–29], as so it is possible
that these channels play a role in the mitotic process.
While the limited access to the mitotic apparatus could
present a barrier to some drugs, DHPs are highly lipophilic
[30] and therefore could reach internal membrane sites. In
this paper, we show that CaV1 channels are localized in
close proximity to mitotic structures. We then use several
experimentalapproachestoassesswhetherthesechannelsare
active participants in cell division in AtT-20 cells.
2. Methods
2.1. Cell Culture. AtT-20/D16v cells are from American Type
Culture Collection (ATCC, Manassas, VA). All cell culture
reagents are obtained from Invitrogen (Carlsbad, CA). AtT-
20 cells are cultured in Dulbecco’s Modiﬁed Eagle medium
(DMEM) containing 4.5gm glucose/L and 10 percent fetal
bovine serum. Cells are maintained at 37◦Ci na5 %C O 2
humidiﬁed incubator and passaged as described previously
[9].Formicroscopy,cellsareplatedonchamberedcoverslips
(Labtek/Nunc, Rochester NY) and grown 2 to 4 days prior
to ﬁxation. For proliferation assays, cells are plated in 8-well
plates (for cell counting) and 96-well plates (for MTS assay)
to be used 2–4 days after plating (∼60%–90% conﬂuence).
For calcium and time-lapse imaging, cells are plated 2–4
days prior to experiments on coated glass bottom microwell
dishes (Mattek Corp, MA). Cells are then transferred to
steroid-free media (Charcoal/Dextran treated FBS; Hyclone,
Logan UT) 12–18 hours prior to ﬁxation.
2.2. Immunocytochemistry. Cells are rinsed brieﬂy
in Phosphate-Buﬀered Saline (PBS), and then ﬁxed
by incubation 20 minutes in PBS containing 4%
paraformaldehyde. Following three washes with PBS,
cells are incubated 5 minutes in 100% methanol at 20◦C.
They are washed again in PBS, and then permeabilized in
PBS containing 20mM NaN3, 0.2% Tween-20, and 0.5%
NP-40. All subsequent washes employ Antibody Wash
Buﬀer (WB; PBS plus 0.2% Tween-20 and 0.05mg/mL
Bovine serum albumin (BSA, IgG free; Sigma, St. Louis
MO). Fixed cells are incubated 24–48 hours at 4◦Cw i t h
one or more primary antibodies diluted into WB (antibody
sources listed below). Following 5 washes with WB, cells are
incubated with the appropriate combination of ﬂuorescent
secondary antibodies (Alexa-ﬂuor conjugates, Invitrogen,
Carlsbad CA) for 1 hour at 22◦C. This is followed by 3
washes, and a ﬁnal rinse with PBS. Stained cells are stored at
4◦C in Slo-fade (Invitrogen); or in Slo-fade containing the
nuclear counterstain DAPI (4 -6-Diamidino-2phenylindole;
Invitrogen). Primary antibodies are obtained from the
following commercial sources: Antibodies to CaV1 channel
alpha1 subunits are from Alomone Labs (Jerusalem, Israel);
Anticentromere (CREST) antibody was from Antibodies
Incorporated (Davis, CA); anti-α tubulin, clone DM1A
from Sigma (St. Louis, MO). The antibodies to CaV1
channel alpha1 subunits are raised in rabbits against peptide
sequences speciﬁc to the CaV1.2 (peptide sequence: TTKIN
MDDLQ PSEN EDKS) and CaV1.3 (peptide sequence:
DNKVT IDDYQ EEAE DKD) isoforms. A basic local
alignment search (Blast; National Center for Biotechnology
Information, http://www.ncbi.nlm.nih.gov/)o fa l ln o n -
redundant protein sequence databases shows no known
protein other than these with greater than 50% sequence
similarity to either of these sequences; similar searches of
the mouse protein database identify the peptide sequences
only in these two channel polypeptides. In tests of speciﬁcity,
we detect no speciﬁc CaV1 staining when the primary
antibody is omitted from the protocol, or when the antibody
is preadsorbed to a ∼10-fold molar excess of peptide antigen
(not shown).
2.3. MTS Assay. Cells are plated at low density in 96-well
plates (5 × 10/well), allowed to grow for 24–48 hours, and
then incubated 72 hours in media to which nifedipine is
added at the concentrations indicated. All wells contain the
same concentration of vehicle, 0.05% DMSO. Cell density
is measured using a modiﬁed methyl tetrazolium protocol
(MTS; Promega Madison WI) according to manufacturer’s
instructions. Data is normalized to absorbance of cells
incubated with vehicle alone and plotted as a function of
nifedipine concentration. All graphs are plotted using Origin
v8 (OriginLab, Northampton MA).
2.4. Confocal Microscopy. We image stained cells at multiple
wavelengths using a Zeiss 510 Meta laser scanning confocal
with inverted microscope stand (Carl Zeiss, Jena, Germany)
using a 63X 1.4NA oil immersion objective. Mitotic stages
are detected by eye using DAPI to visualize chromosome
morphology; due to the limitation of the confocal system
to 3 color channels, imaging of chromosomes was not
possible in addition to the proteins described. All channels
are imaged sequentially, and images are stored as chunky
RGB ﬁles. Figures are assembled using Adobe PhotoshopInternational Journal of Cell Biology 3
(ver. 7.0). Images with four labels (Figure 1(A)) display
some bleedthrough of the microtubule staining into the
CRESTstaining.WecorrectedforthisusingMetaMorphv4.5
software (Molecular Devices, Sunnyvale CA) by calculating
the relative intensity of microtubules in both the CREST
and microtubule images, multiplying the microtubule image
by the value and subtracting the resultant image from the
CREST image.
2.5. Visual Mitotic Stage Assay. Cells are plated at low density
(5 × 103/well) in chambered cover slips (Labtek/Nunc,
Rochester NY), allowed to attach for 24–48 hours, and then
incubatedeither24or72hoursinmediacontainingNifedip-
ine (6μM). Multiple ﬁelds (minimum of 5 per condition) of
AtT-20 cells at similar cell density are randomly selected and
imaged with a Hamamatsu ORCA-ER camera mounted on a
Leica DMIRB inverted microscope equipped with a mercury
lamp and DAPI ﬁlter cube and 40X 1.25NA objective. The
number of cells in each stage is determined using “Manually
Count Objects” application in MetaMorph. We group cells
identiﬁed in anaphase, telophase, or cytokinesis into a single
class (A/T/C) in our analysis due to the low mitotic index
and the diﬃculty in diﬀerentiating among these phases using
chromosome morphology alone.
2.6. Time-Lapse Microscopy. Time series of DIC images
are acquired as described above using a 30-second time
interval. Cells are maintained in covered dishes at 37◦Co v e r
the course of the imaging session to minimize changes in
osmolarity. We deﬁne a signiﬁcant mitotic “block” as any
stage in which time elapsed is equal to or greater than
two standard deviations of the mean time required for that
stage by control cells. For Fura PE3/AM AtT-20 cells are
imaged by DIC on a Nikon TE2000U inverted microscope
with a 100X 0.5–1.3NA S Fluor objective with the iris
collar set to 1.3NA using a DVC 1312 monochrome CCD
camera (DVC Co.) controlled with Simple PCI software
(v5.3, Hamamtsu, Inc.). Cells are kept at 37◦C using an air
current incubator (AirTherm). To ascertain that the eﬀects
on cell cycle progression are not a function of the imaging
setup or cell culture conditions, a prophase cell is imaged for
the entire mitotic cycle (∼1.5 hours) without the addition
of Fura PE3/AM (4μM) on each experimental day. We then
exclude all data collected on days when the control cells
do not complete the entire mitotic cycle within the mean
time ±1 S.D. Experimental dishes are incubated with Fura
PE3/AM(4μM)at37◦Cfor20minutespriortoDICimaging
of mitosis versus vehicle controls (DMSO).
2.7. Calcium Imaging. Fluo-4 ﬂuorescence is imaged in live
cells on a Nikon TE2000U inverted microscope a DVC
1412 Intensicam II. The DIC and ﬂuorescence images are
acquired simultaneously using a long pass 610nm ﬁlter for
the DIC illumination, a dual camera adapter connected
to the camera port, and a 565nm dichromatic mirror in
the dual-camera adapter to direct the ﬂuorescence emission
light to the DVC 1412 Intensicam II and the DIC image
to a DVC 1312 camera. A Sutter DG-4 xenon arc lamp
source and fast ﬁlter changer are used for illumination of
ﬂuorescence and selection of excitation wavelengths. An
FITCﬁltersetismountedinthemicroscopestandwithwhite
light delivered from the DG-4. Fluorescence illumination
andallimageacquisitionsarecontrolledusingtheSimplePCI
image acquisition software running on two PC computers,
one for each camera. To minimize phototoxicity to the cells
from excessive ﬂuorescence excitation, every one minute
a set of 10 images is acquired at a 1 second interval.
The rapidity of the acquisition pattern is due to the short
duration of anaphase (minutes). Signal intensity of multiple
areas in the time-lapse image series is determined using
the intensity measurement functions in the SimplePCI
software.
3. Results
3.1. CaV1.2 and CaV1.3 Localize to the Mitotic Appara-
tus. Figures 1(A) and 1(B) show the pattern of staining
observed for CaV1.2 and CaV1.3, respectively, for AtT-20
cells captured and ﬁxed at diﬀerent stages in mitosis. To
visualizethekinetechoresinmetaphase,cellsarestainedwith
a kinetechore antibody (CREST antibody) in addition to
antibodies to CaV1.2 and CaV1.3. Costaining demonstrates
that CaV1.2 localizes to sites adjacent to the “poleward” of
the kinetechores in both metaphase and anaphase (Figures
1(A), (a), (b), inserts). Of note, this distribution of CaV1.2
with kinetechores during metaphase is seen throughout the
volume of the cell as imaged using z-stacking across the
entirety of the spindle apparatus (not shown) and supports
that the localization is within the AtT-20 cell and not
superimposed imaging from surface proteins.
To visualize the microtubules of the mitotic spindle, cells
are also costained with the α-tubulin antibody DM1A. In
telophase, we observed CaV1.3 (Figure 1(B), panel (a)) at
the mid-spindle zone of the mitotic apparatus; we do not
observe a similar pattern with CaV1.2 (Figure 1(A), panel
(a)). However, as the microtubules condense further to form
the midbody during cytokinesis, both CaV1.2 and CaV1.3
are then visualized at the midbody (Figure 1(A) panel (c),
and Figure 1(B) panel (b)). These staining patterns suggest
that the cells direct an active, isoform-speciﬁc redistribution
of CaV1 channels over the course of the cell division cycle.
To test if the mitotic channel distribution occurs in other
cell types, we examined the distribution of CaV1 channels
in two additional cell lines of neuroendocrine origin: PC12
pheochromocytoma cells and INS-1 beta pancreatic cells.
Both of these cell types are known to express CaV1 channels
[31, 32]. Figure 1 shows that, as in AtT-20 cells, both CaV1.2
(Figure 1(A) panel (d)) and CaV1.3 (Figure 1(B) panel (c))
are localized to the midbody in PC12s during cytokinesis. In
contrast, we did not see a similar pattern of CaV1 staining
in INS-1 cells undergoing mitosis; the CaV1.3 channels
are visible at midbody whereas the CaV1.2 channels are
not (Figure 1(A), panel (g); Figure 1(B), panel (e)). Speciﬁc
staining for both isoforms was readily visible in interphase
cellsasreportedpreviously[31].Thesediﬀerencesinchannel
isoform staining support the idea that the patterns we
o b s e r v ea r ed u et or e a ld i ﬀerences among neuroendocrine4 International Journal of Cell Biology
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Figure 1: Calcium channel CaV1.2 and CaV1.3 localization in mitotic cells. 1(A) compares CaV1.2 staining in AtT-20 cells (a)–(c), PC-12
cells (d), and INS-1 cells (e)–(g). CaV1.2 is located with kinetechores at the “poleward side” during metaphase and anaphase ((a), (b): inset)
in the AtT-20 cells. Midbody CaV1.2 staining is observed in both AtT-20 cells and PC-12 cells (c), (d) but not in INS-1 cells (g). 1(B) is
a similar comparison for CaV1.3 and shows staining at the mid-spindle zone only in AtT-20s during telophase (a). In contrast, all three
neuroendocrine cell types display CaV1.3 staining at the midbody during cytokinesis ((B): (b), (c), and (e)). 1(C) shows control staining of
Cos7cells;inparticular,notethatthereisnononspeciﬁcstainingatthemidbodyofthesecells(1(C)(c),(e)).CaV1.2andCaV1.3arestained
with antibodies speciﬁc to alpha subunit sequences for CaV1.2 and CaV1.3 (see Methods, Alamone Labs) and detected with secondary goat
anti-rabbit antibody Alexa 555 (red); Microtubules are stained with DM1A and goat anti-mouse Alexa 647 (blue); kinetechores are stained
with anti-CREST antibody and Alexa 488 (green). Bleedthrough between microtubule and CREST staining channels was corrected for as
described in methods.International Journal of Cell Biology 7
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Figure 2: Nifedipine attenuates AtT-20 Cell density.( a )Cell viability. Incubation with the DHP CaV antagonist, nifedipine, results in a
dose-dependent decrease in AtT-20 cell number using the colorimetric MTS assay for cell viability. The half maximal dose for this eﬀect
is 1.5 ± 0.3μM nifedipine. Graph shows normalized data from 3 experiments. (b) Cell proliferation and mitotic stages. Graph shows mean
number of cells ±S Ef o ra tl e a s t5ﬁ e l d s( ≥ 800 total cells counted for Day 3 for each condition). There is a signiﬁcant decrease in the total
number of cells counted between vehicle control and nifedipine-treated cells (∗P< . 05). There is also a parallel decrease in later phases of
mitosis (A/T/C) (∗P<. 05). Nifedipine = 6μM; Vehicle = DMSO from which nifedipine is diluted from 10mM stock solution. (c) Time
for transition through mitosis. Measurements for individual AtT-20 cells using time-lapse microscopy. The time from prophase to cytokinesis
is depicted for both control (Vehicle) and Nifedipine-treated cells. The mean time for completion of mitosis is indicated by the bold line
with the dotted lines representing 2 S.D. from the mean. Nifedipine treated cells show a shift in mean time to complete mitosis as well as an
increased number of cells that do not complete mitosis (block) within the 2 S.D. time limit compared to control cells.
cell types, and not simply a nonspeciﬁc antibody interaction
with mitotic structures.
As another test of speciﬁcity we performed the identical
imaging protocol using the epithelial-derived Cos 7 cells
that lack CaV1 channels [33, 34]. Figure 1(C) shows that in
these cells we detect only background staining suggestive of
nonspeciﬁc binding of the antibodies; no pattern speciﬁc to
the mitotic apparatus is seen.
3.2. Incubation with CaV1 Antagonist, Nifedipine, Attenuates
Cell Proliferation. To test for a potential role for CaV1 chan-
nelsinmitosis,weexaminedtheeﬀectofthedihydropyridine
(DHP) CaV1 antagonist, nifedipine, on cell growth using
a standard assay of cell viability (MTS; see Methods). Cells
are cultured in the presence of varying concentrations of
nifedipine for ∼72–96 hours. The eﬀect of nifedipine on cell
divisionwasassessedbymeasuringcelldensityfollowingthis
incubation. We used this prolonged incubation to amplify
any potential eﬀect of nifedipine on cell division. Figure 2(a)
shows a dose-dependent attenuation of cell growth by
nifedipine. The maximal eﬀect approaches a 60% decrease
in cell density after three days of incubation, corresponding
to an approximately 2.5-fold decrease in growth rate. The
IC50 for this eﬀect is approximately 1.5μM, a value that
is substantially higher than the IC50 measured for DHP-
induced blockade of ACTH release [9]. While the role
of the CaV1 isoforms 1.2 and 1.3 in secretion has not
been unequivocally established, recent work in INS-1 cells
demonstrates that only the CaV1.2 isoform is coupled to
secretion [31]. In addition, there is evidence that the CaV1.3
channel has a lower aﬃnity for DHPs than the CaV1.2
isoform [35], and thus may represent the target responsible
for eﬀects of nifedipine on cell proliferation we observe.
3.3. Incubation with Nifedipine Results in an Apparent Shift in
Mitotic Stage. We next examined the eﬀect of nifedipine on8 International Journal of Cell Biology
cellproliferationusingadirectcellcountingassay.Treatment
of ﬁxed AtT-20 cells with the nuclear stain (DAPI) allows
us to identify cells at various mitotic stages according to
chromosome morphology. To maximize our ability to detect
a DHP-sensitive eﬀect on mitotic cells given the small
percentage of cells undergoing cell division at any one time
(4%–6%), we counted an average of 800 cells/condition
using at least 5 diﬀerent ﬁelds imaged (shown as the average
no. cells/ﬁeld). First, we observed a signiﬁcant decrease in
cells per ﬁeld in the presence of nifedipine (Figure 2(b),
Control versus Nifedipine, P<. 05). Second, although the
total percentage of cells undergoing mitosis is essentially
unchanged in the presence of nifedipine (4%–6%), within
the mitotic population we observe a signiﬁcant decrease in
the percent of A/T/C cells (Anaphase/Telophase/Cytokinesis;
Figure 2(b), P<. 05). This shift, along with the observed
cumulative decrease in cell number over time in nifedipine,
is indicative of a block in mitosis that occurs prior to the
cell entering anaphase. The cumulative nature of the eﬀect
suggests that as additional cells enter the mitotic cycle, more
stall and are unable to proceed to complete cell division. We
alsodonotdetectanyobviouschangeinspindlemorphology
in response to incubation with nifedipine. Finally, we believe
that this decrease is likely due to an eﬀect on cell division and
not on apoptosis in that we ﬁnd no evidence for either DNA
laddering or other markersofapoptosis innifedipine-treated
AtT20 cells (not shown). Calcium channel block is generally
associated with a protective eﬀect in models of apoptotic cell
death [36].
3.4. Nifedipine Induces a Phase-Dependent Block in Mitosis.
As another approach to examining the eﬀects on nifedipine
on mitosis, we next used a direct time-lapse microscopy
assessment of individual cell division. AtT-20 cells are
imaged in the presence of 6μM nifedipine (or vehicle
control, DMSO) at diﬀerent stages (Interphase through
Cytokinesis) to determine the average time spent in each
mitotic stage under these two conditions. Figure 2(c) shows
the eﬀect of nifedipine on the progression of cells in
prophase/prometaphase/metaphasetoanaphase.Nifedipine-
treated cells display a block in mitotic progression (52%;
n = 23 cells) versus control cells (15%; n = 26 cells;
P ≤ .05). The magnitude of this DHP-induced block can
be expressed as a “mean time to complete mitosis” (vertical
line ±2 standard deviations, dotted lines). The mean time
from prophase to cytokinesis is shifted in nifedipine treated
cells (bottom panel) although there is an overlap between
the two groups. In other words, both control and nifedipine
treated cells can “stall” in prometaphase/metaphase, but this
phenomenon occurs more frequently in the presence of
nifedipine. In cells observed over a prolonged time course we
observe cells undergoing chromosome decondensation and
reversion to interphase. Finally, although cell death could be
observed, it is seen in both control and nifedipine-treated
cells, particularly those imaged over a longer time course
(e.g., hours).
3.5. Calcium Chelation Disrupts Mitosis. We next examined
the eﬀects of several calcium-sensitive dyes, both for their
potential eﬀects on mitosis (due to calcium chelation) and as
a tool to detect calcium transients in mitotic AtT-20 cells. As
reported in other systems [13, 14], we ﬁnd that treatment of
AtT-20 cells with the calcium indicator Fura PE3/AM (4μM)
disrupts mitosis at all stages prior to anaphase (Figures 3(b),
3(c)). In contrast, if Fura PE3/AM is added to a cell already
in anaphase/telophase, mitosis proceeds without obvious
delay (Figure 3(d)). To ascertain if diﬀuse cell injury was
occurring in response to chelation of intracellular calcium by
the presence of Fura PE3/AM, we imaged interphase cells (or
“nondividing”) to observe if spontaneous action potentials
that can be seen in AtT-20 cells could be observed by mea-
suringtheconcomitantcalciumtransients.AsseeninFigures
3(b)and3(c), relativeﬂuorescencecorresponding tocalcium
spikes detected using Fura PE3/AM could be measured in a
nearby interphase cell (arrow), showing that the cells could
still exhibit electrical activity after Fura PE3/AM loading;
this is displayed graphically in Figure 3(c). The eﬀect of
Fura PE3/AM is, therefore, consistent with published reports
demonstrating that perturbation of intracellular calcium
can lead to disruption of mitosis. This “chelation eﬀect”
is distinct from the changes in intracellular calcium levels
that may occur due to CaV1, particularly in nondividing
cells. However, it is provocative that both calcium chelation
and DHP-induced blockade of CaV channels result in a
prometaphase block in mitosis, suggesting that the intra-
cellular calcium requirement for mitosis may be uniquely
relevant to this stage in mitosis.
3.6.CalciumTransientsColocalizewithDistributionofCaV1.2
and CaV1.3. Fura PE3/AM chelation demonstrates a clear
calcium-dependence of mitosis, at least in stages prior to
anaphase. However, due to this disruption, this dye does
not permit calcium imaging in these cells. To image calcium
transients we used Fluo-4, a calcium indicator dye with
al o w e ra ﬃnity for free calcium. The calcium dissociation
constant (KD) for Fura PE3/AM is 250nM, while that for
Fluo-4 is 400nM. Using the lower aﬃnity dye, cells are able
to proceed through mitosis to allow detection of calcium
ﬂuxes at the midbody region (Figure 4(a)) as identiﬁed by
simultaneous DIC imaging (Figure 4(b)), as well as in the
regionofthemid-spindlezone.Again,theseregionscorrelate
with the aforementioned immunocytochemical localization
of CaV1.2 and CaV1.3 channels.
The intracellular calcium transients measured at these
sites are clearly above that of the nuclear region of a
nearby interphase cell (area 4) and the background (area
5) as shown in Figure 4(c). In addition, the measured
elevation in intracellular calcium levels at the sites in
the midbody region (areas 1–3) is unlikely to be due a
“volumetric eﬀect” of increased ﬂuorescent probe, since the
midbodyandtheadjacentregionsarehighlyconstrictedand,
therefore, represent a much smaller volume than the areas
measured in the cytoplasm. Consequently, one would expect
a potential under-representation, not over-representation, of
calcium concentrations. Unfortunately, as shown with Fura
PE3/AM above, ratiometric analysis was possible. It would
beinteresting todetectchangesinintracellularcalciumlevels
at more punctate sites in which CaV1s are also visualizedInternational Journal of Cell Biology 9
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Figure 3: Calcium chelation with fura PE3/AM interrupts speciﬁc stages of mitosis. Addition of Fura PE3/AM (4μM) results in a cessation
and/or regression of mitotic stages prophase (b) and metaphase (d). However, progression from anaphase to cytokinesis is unaﬀected (f).
(a), (c) and (e) are controls for comparison; images are captured at 30-second intervals as described in Methods; times for these images are
as indicated in lower right of each panel. In the control cell (a) prometaphase proceeds to metaphase within 51 minutes and continues to
cytokinesis within 1minute 18 seconds. In contrast, in the Fura PE3/AM-treated prometaphase cell (b), chromosomes decondense and no
mitotic progression is seen in > 60 minutes. Similarly, in the presence of Fura PE3/AM, metaphase cells show chromosomes aligned but do
not progress in > 30 minutes (d). In the presence of Fura PE3/AM, anaphase progresses normally to cytokinesis (f).
by immunoﬂuorescence, such as at the kinetechores during
metaphase.
4. Discussion
Although a role for calcium in mitosis has been implicated
for approximately 2 decades, the critical source of the cal-
cium has not, to date, been demonstrated. Data in this paper
provide evidence for an intriguing possible role for CaV1-
typecalciumchannelsinmitosisofAtT-20corticotrophs.We
canidentifyCaV1.2immunoreactivityatthe“polewardside”
ofthekinetechores, CaV1.3 immunoﬂuorescenceatthemid-
spindle zone, and both CaV1.2 and CaV1.3 isoforms at the
midbody. In addition, we are able to image calcium ﬂuxes
at sites that correspond to the mid-spindle zone (CaV1.3)
and at the midbody (CaV1.2 and CaV1.3). Unfortunately,
calcium imaging at other stages of mitosis is beyond the
detection threshold of our current studies. However, the
isoform-speciﬁc associations with discrete mitotic struc-
tures, taken together with the concomitant calcium signal
intensity changes, are consistent with a functional role
for these channels during cell division. Additionally, there
are parallel stage-speciﬁc perturbations in the presence of
a DHP antagonist as well as calcium chelation. Whereas
chelation of intracellular calcium blocks mitosis at all phases
prior to that of anaphase, incubation of cells with the
CaV1 antagonist, nifedipine, results in a decrease in cellular
proliferation that appears to be due to a “prometaphase10 International Journal of Cell Biology
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Figure 4: Sites of calcium transients during mitosis. Calcium tran-
sients correspond with sites of CaV1 immunoﬂuorescence in AtT-
20 Cells during mitosis. Simultaneous imaging of (a) Fluo4 (4μM)
intracellular calcium transients and (b) cell morphology by DIC in
AtT-20 cells during cytokinesis. Regions: 1=midbody; 2, 3=spindle
mid-zone; 4=nuclear region of interphase cell; 5=background
(media only). (c) Plot of ﬂuorescence units for each region over
time (sec). Regions of enhanced calcium transients correspond to
midbody (1) and spindle mid-zone (2, 3). Break in X-axis marks
time of acquisition following loading of Fluo-4.
block.” Although mechanistically diﬀerent, it is interesting to
note that intracellular calcium levels appear to play a pivotal
role at this juncture in mitosis.
Evidence for a role of calcium in mitosis in at least
some cell types is long-standing [13, 20]. In contrast, there
is little evidence of a role for calcium channels in mitosis,
although cell-cycle-dependent expression of CaV1 and CaV3
calcium currents in smooth muscle cells has been reported
[37]. Stage-dependent sensitivity to changes in calcium
levels has also been described. For example, Groigno and
Whitaker [38] demonstrated a rise in intracellular calcium
at anaphase in sea urchin embryos; this rise in calcium
and the associated chromosome separation can be blocked
with calcium chelation and restored with activation of caged
calcium. Chandra [19] reported a redistribution of calcium
stores in LLC-PK1 cells, an alignment of calcium with the
mid-spindle zone prior to anaphase.
Given that CaVs are integral membrane proteins, our
observations imply that the CaV channels must somehow
transit from the cell surface to locations near mitotic struc-
tures in a phase-speciﬁc process. Many previous studies have
demonstrated the importance of membrane reorganization
during mitosis [37–42]. Early evidence by Pawaletz and
Fehst[37]demonstratedprogressiveaccumulationofvesicles
around the mitotic apparatus in HeLa cells. During the
course of mitosis vesicles are noted around chromosomes
as the nuclear envelope disappears during prometaphase,
over the entirety of the mitotic apparatus during metaphase,
and then vesicles are detected at the mid-spindle zone
and midbody, but then reaccumulate around the Golgi
apparatus during telophase as it reappears during this phase.
Waterman-Storer et al. [39] found membrane distribution
during mitosis in both PtK2 and LLC-PK1 cells labeled with
the membrane dye, DiOC6, and showed a redistribution of
membrane at prophase, with tubular membrane structures
aligning with the kinetechore spindles in prometaphase.
Kirchhausen and colleagues have shown that mitosis is
associated with a shift in the equilibrium of membrane
recycling that results in a net decrease in plasma membrane
and in cell size [41, 42]. This process of internalization
and reorganization of plasma membrane involves SNARE-
related proteins, such as Syntaxins, particularly at later stages
of cell division [42–45]. Since Syntaxins and other SNARE
proteins also function in exocytosis, it is provocative that
our observations represent a potential parallel phenomenon,
especiallysincetherearemanystudiesthatdemonstrateboth
directandindirectinteractionsbetweenSNAREproteinsand
CaV channels [6].
The sites at which we observe CaV1 channels suggest
a unique role for intracellular calcium prior to anaphase.
For example, in metaphase there exist several “checkpoints”
that regulate mitotic progression until all chromosomes are
aligned at the metaphase plate and properly attached to the
microtubules of the mitotic spindle. It follows, therefore,
that this phase could be a sensitive stage to both nifedipine
and calcium chelation, with the decrease in intracellular
calcium providing a common mechanism. After metaphase,
the cell proceeds to anaphase as sister chromatids are pulled
apart by the mitotic spindle, a process that relies on proper
microtubule attachment at the kinetochores. The presence
of CaV1.3 at the mid-spindle zone is, therefore, also of
interest. It is curious, however, that neither exposure to
nifedipine, nor chelation of calcium, blocks the progression
of anaphase in the AtT-20 cells. One possibility is that the
traﬃcking of channels discussed above may place the targets
for nifedipine in less accessible internal sites. However, the
lack of eﬀect of chelation of intracellular calcium after the
initiation of anaphase also raises the possibility of parallel
pathways participating at this critical juncture.
Finally, it is intriguing that incubation with the DHP
antagonist, nifedipine, produces a decrease in cell density
that is consistent with a block prior to anaphase. Previous
studies of DHP eﬀects on cellular proliferation demonstrateInternational Journal of Cell Biology 11
an inhibition of mitosis in vascular smooth muscle [29]a n d
in sympathetic neuroblasts [26]. In PC12 cells nifedipine has
also been shown to inhibit cellular diﬀerentiation [46]; this
observationmayberelatedtocurrentvisualizationofCaV1.2
and CaV1.3 at the midbody in this neuroendocrine cell line.
Takentogetherwiththesestudies,ourdataprovidesevidence
that localization of CaV channels at the mitotic apparatus
may contribute to the mechanism(s) by which DHPs have
been successful as adjunctive agents in chemotherapeutic
regimens [47].
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